MTOR and cervical carcinoma: Several groups also used NVP-BEZ235 and new 1,3,5-triazine derivatives to double block PI3K/mTOR signaling pathway to inhibit the proliferation of cervical cancer cells, so as to enhance the therapeutic response (79, 80).